Alset Inc. is Director & 10% Owner at IMPACT BIOMEDICAL INC. (IBO). They have made 3 open-market trades across 2 companies since 2024, most recently 2025-04-04.
CIK 0001750106
2 open-market purchases totalling $8.2M since 2024, against 1 sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.